The Study to Explore Early Development (SEED) - Phase 3

ICR 201910-0920-002

OMB: 0920-1171

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2017-03-16
Supplementary Document
2017-03-16
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2019-10-11
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2016-10-27
Supplementary Document
2019-10-11
Supplementary Document
2016-10-19
Supplementary Document
2016-10-19
Supplementary Document
2016-10-19
Supporting Statement B
2019-10-11
Supporting Statement A
2019-10-11
IC Document Collections
IC ID
Document
Title
Status
224190 Unchanged
224189 Unchanged
224188 Unchanged
224186 Unchanged
224184 Unchanged
224183 Unchanged
224182 Unchanged
224167 Unchanged
224166 Unchanged
224165 Unchanged
224164 Unchanged
224163 Unchanged
224156 Unchanged
224023 Unchanged
224022 Unchanged
224021 Unchanged
224020 Unchanged
224019 Unchanged
224018 Unchanged
224017 Unchanged
224016 Unchanged
224015 Unchanged
224014 Unchanged
224013 Unchanged
224012 Unchanged
224011 Unchanged
224009 Unchanged
ICR Details
0920-1171 201910-0920-002
Historical Active 201610-0920-010
HHS/CDC 0920-1171
The Study to Explore Early Development (SEED) - Phase 3
Extension without change of a currently approved collection   No
Regular
Approved without change 12/03/2019
Retrieve Notice of Action (NOA) 10/16/2019
Previous terms continue: Approved consistent with the understanding that tokens of appreciation offered to participants in the study will not be offered prior to agreement to participate in the full study (i.e., no incentives offered for eligibility screening).
  Inventory as of this Action Requested Previously Approved
12/31/2021 24 Months From Approved 03/31/2020
11,447 0 11,447
7,118 0 7,118
0 0 0

SEED is a multi-state case-control study designed to investigate risk factors for Autism Spectrum Disorders (ASDs) and the health and behavioral characteristics of children with ADS. SEED is specifically designed focused on preconception, prenatal, perinatal and early postnatal risk factors with primary emphasis on genetic, infectious, immunological, hormonal, and obstetric risk factors.

US Code: 42 USC 247b-4 Name of Law: The Combating Autism Act of 2006
   US Code: 42 USC 301(a) Name of Law: PHSA
   PL: Pub.L. 109 - 416 409c Name of Law: The Children's Heath Care Act of 2000
  
None

Not associated with rulemaking

  84 FR 24144 05/24/2019
84 FR 51588 09/30/2019
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 11,447 11,447 0 0 0 0
Annual Time Burden (Hours) 7,118 7,118 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$6,702,262
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Thelma Sims 4046394771

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
10/16/2019


© 2024 OMB.report | Privacy Policy